Related Experiment Videos
Approach to therapy of respiratory infections in the critical care setting
1Clinical Research Department, Cutter Biological, Miles Inc, Berkeley, California 94701.
Abstract:
Therapy of pneumonia in the critical care setting includes intravenous antibiotics and supportive care. Since the etiologic agent of infection may not be clear, empiric broad-spectrum antibiotic regimens are often used. Combinations of beta-lactam and aminoglycoside agents are particularly popular regimens due to the high incidence of gram-negative bacillary and Staphylococcus aureus pneumonias in the critical care unit. Several new approaches to treatment of pneumonia in the critical care setting are being evaluated, including single-agent empiric coverage using a broad-spectrum beta-lactam agent; broad-spectrum quinolones, such as ciprofloxacin; intrabronchial aminoglycoside instillation therapy; and passive immune therapy with immunoglobulins and monoclonal antibodies.
Insights
Critical care pneumonia treatment involves antibiotics and supportive care. New strategies explore single broad-spectrum agents, quinolones, and immunotherapy for better patient outcomes.
Area of Science:
- Critical care medicine
- Infectious diseases
- Pharmacology
Background:
- Pneumonia in critical care requires prompt treatment with intravenous antibiotics and supportive care.
- Empirical broad-spectrum antibiotic regimens are common due to unclear causative agents.
- Gram-negative bacillary and Staphylococcus aureus pneumonias are prevalent in critical care units.
Purpose of the Study:
- To review current and emerging therapeutic strategies for pneumonia in the critical care setting.
- To highlight the rationale behind common antibiotic choices and explore novel treatment approaches.
Main Methods:
- Literature review of current practices and emerging therapies for critical care pneumonia.
- Analysis of antibiotic regimens, including combinations and single-agent strategies.
- Evaluation of novel approaches such as quinolones, intrabronchial instillation, and immunotherapy.
Main Results:
- Combination therapy (beta-lactam and aminoglycoside) is a popular empirical regimen.
- New approaches under investigation include single broad-spectrum beta-lactams, ciprofloxacin, intrabronchial aminoglycosides, and passive immunotherapy.
Conclusions:
- Current pneumonia treatment in critical care relies on broad-spectrum antibiotics and supportive measures.
- Ongoing research focuses on optimizing empirical therapy and exploring innovative treatments like immunotherapy for improved efficacy.